Abstracts & Talks

Highlighted Abstracts & Talks -

  • Clonal dynamics and CSS, a clinical seven-feature risk score, predict relapse in single-cell MRD analysis of AML patients. Learn More.
  • Dissecting the clonal distribution of IKZF1 copy number deletions in adult Ph- B-cell ALL. Learn More.
  • Pattern of clonal hematopoiesis mutations in CLL reveals potentially new mechanistic insights. Learn More.
  • TET2 and IDH1/2 mutations are not strictly mutually exclusive: clonal architecture and disease context determine co-occurrence patterns in myeloid malignancies. Learn More.
  • Sensitivity of NPM1 mutated AML to venetoclax is associated with NIBAN1. Learn More.
  • Dual menin/FLT3 blockade by bleximenib and gilteritinib facilitates myeloid differentiation and extends survival in NPM1/FLT3 co-mutated AML PDX models. Learn More.
  • Mutant CALR-specific monoclonal antibody INCA033989 produced molecular responses and restored normal hematopoiesis in patients with essential thrombocythemia in Phase 1 studies. Learn More.
  • Multiomic single cell sequencing can accurately diagnose BCR::ABL1+ AML as separate from blast crisis CML. Learn More.
  • Complementary single-cell DNA and bulk transcriptomic profiling reveals myeloid distribution of UBA1-mutant clones and depletion of an early lymphoid program in VEXAS syndrome. Learn More.
Customer Quote

Tapestri Triomics: DNA, RNA and protein from the same cell
Know which cells carry the mutation, what they’re expressing and how they present, measured directly rather than inferred.

“Triomics allows us to move beyond identifying which cells carry an ASXL1 mutation and begin asking what that mutation means for their biology. Integrating genotype, transcriptome, and protein in the same cell gives us a deeper understanding of myeloid disease progression.”

Dr. Terra Lasho, PhD, Assistant Professor Of Medicine, Mayo Clinic

Dr. Terra Lasho, PhD, Assistant Professor Of Medicine, Mayo Clinic

Watch: How cells interpret mutations in hematologic malignancies
Terra Lasho, PhD, Mayo Clinic, on tracing TET2 and IDH clones across CMML and AITL with single-cell DNA, protein and Triomics.
[Watch on demand]

Let's Meet at ASH 2026

Book time with our scientists to see Triomics, review your project or dig into the data behind this year’s presentations.

Request quote